"The problem that trainers are looking to solve is finding and keeping new clients. For clients? They don't need another tool to find new content. They want the 'answer.' Jijo is a match.com for clients, and a Shopify on steroids for trainers," states Charles Friedberg, Founder & CEO. Charles has 25 years in financial services and as a (former) 'outsider' looking in to the HALO sector, he found a need that simply wasn't being addressed. He continues, "The problem isn't trainers not knowing how to post stuff on the Internet. It's how do they attract and keep clients? It's improving the LTV of the client, while simultaneously lowering the cost of acquisition." Charles and Pete chat about the digital landscape, the relationships between brands and the trainers, and more.
Charles Friedberg, Jijo, Founder & CEO
Get every new HALO Talks episode!
Each week, host Pete Moore sits down with the founders, operators, finance execs, and investors shaping the Health, Active Lifestyle, and Outdoor sector. Get new episodes in your inbox, no hype or BS, just the people building the sector.
Email has been submitted.
Recent Episodes
- Episode #618: Med Spa Expansion, Regulation, and Niches-Insights from Amanda Guarniere of GuardianMD
- Episode #617: From the Marines to Boardrooms-Jon Sheldon's Lessons on Leadership and Team Dynamics
- HALO Talks Fast Break: Revolutionizing Club Benefits-Amy Bach on Welld Health's Impact Across 10,000 Locations
- Episode #616: Regenerative Medicine, Market Education, and the Future of Wellness-Insights from Bill Quateman
- Episode #615: Inside Austin Pickle Ranch with Tim Klitch-Growth, Community, and Private Equity in Pickleball
- Episode #614: Building Sweathouz (SWTHZ)-Nico Varano on Scaling, Unit Economics, and Operational Excellence
- Episode #613: SoulFire's Formula-Blending Brand Identity, Community, and Profitability in Boutique Fitness
- Episode #612: Building Community Through Contrast Therapy-Carrie Bacon's Vision for 180 Degree Bathhouse
- Episode #611: Outpatient Innovation-Dr. Munir Ghesani Discusses Theranostics, Expansion, and Clinical Trials
- See all →